163 related articles for article (PubMed ID: 38556189)
1. Advances in Nonresponsive and Refractory Celiac Disease.
Malamut G; Soderquist CR; Bhagat G; Cerf-Bensussan N
Gastroenterology; 2024 Jun; 167(1):132-147. PubMed ID: 38556189
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Green PHR; Paski S; Ko CW; Rubio-Tapia A
Gastroenterology; 2022 Nov; 163(5):1461-1469. PubMed ID: 36137844
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade.
Elli L; Soru P; Roncoroni L; Rossi FG; Ferla V; Baldini L; Nandi N; Scaramella L; Scricciolo A; Rimondi A; Fusco N; Croci GA; Gianelli U; Cro L; Barbieri M; Lombardo V; Costantino A; Vaira V; Ferrero S; Tontini GE; Barigelletti G; Fabiano S; Doneda L; Vecchi M
Dig Liver Dis; 2023 Feb; 55(2):235-242. PubMed ID: 36096991
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in celiac disease and refractory celiac disease.
Malamut G; Cording S; Cerf-Bensussan N
F1000Res; 2019; 8():. PubMed ID: 31297187
[TBL] [Abstract][Full Text] [Related]
5. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
6. Refractory celiac disease.
Malamut G; Murray JA; Cellier C
Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
[TBL] [Abstract][Full Text] [Related]
7. ACG clinical guidelines: diagnosis and management of celiac disease.
Rubio-Tapia A; Hill ID; Kelly CP; Calderwood AH; Murray JA;
Am J Gastroenterol; 2013 May; 108(5):656-76; quiz 677. PubMed ID: 23609613
[TBL] [Abstract][Full Text] [Related]
8. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.
Cellier C; Delabesse E; Helmer C; Patey N; Matuchansky C; Jabri B; Macintyre E; Cerf-Bensussan N; Brousse N
Lancet; 2000 Jul; 356(9225):203-8. PubMed ID: 10963198
[TBL] [Abstract][Full Text] [Related]
9. Current pharmacological approaches and potential future therapies for Celiac disease.
Kulkarni A; Patel S; Khanna D; Parmar MS
Eur J Pharmacol; 2021 Oct; 909():174434. PubMed ID: 34418405
[TBL] [Abstract][Full Text] [Related]
10. Refractory celiac disease.
Abdallah H; Leffler D; Dennis M; Kelly CP
Curr Gastroenterol Rep; 2007 Oct; 9(5):401-5. PubMed ID: 17991341
[TBL] [Abstract][Full Text] [Related]
11. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
12. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
13. [Celiac disease].
Malamut G; Cellier C
Rev Med Interne; 2010 Jun; 31(6):428-33. PubMed ID: 20359791
[TBL] [Abstract][Full Text] [Related]
14. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
15. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease.
Croese J; Giacomin P; Navarro S; Clouston A; McCann L; Dougall A; Ferreira I; Susianto A; O'Rourke P; Howlett M; McCarthy J; Engwerda C; Jones D; Loukas A
J Allergy Clin Immunol; 2015 Feb; 135(2):508-16. PubMed ID: 25248819
[TBL] [Abstract][Full Text] [Related]
16. Management of celiac disease in daily clinical practice.
Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
[TBL] [Abstract][Full Text] [Related]
17. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
18. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease.
Leon F
J Immunol Methods; 2011 Jan; 363(2):177-86. PubMed ID: 20833175
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of refractory sprue].
Garrido A; Guerrero FJ; Lepe JA; Ortega C; Muñoz E
Gastroenterol Hepatol; 2002 Dec; 25(10):594-6. PubMed ID: 12459121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
